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1. Introduction 
According to various studies, fats of animal and vegetable origins satisfy 22% to 42% of the 
daily energy demands of human beings (Srinivasan et al., 2006; Wagner et al., 2008; Willet, 
2006). Some fats, and especially those that are hydrogenated, contain trans fatty acids 
(TFAs), i.e. unsaturated fatty acids with at least one double bond in a trans configuration 
(Craig-Schmidt, 2006). This trans-double-bond configuration results in a greater bond angle 
than for the cis configuration, thus producing a more extended fatty-acid carbon chain that 
is more similar to that of the saturated fatty acids (SFAs), rather than to that of the cis-
unsaturated double-bond-containing fatty acids (Fig. 1) (Moss, 2006; Oomen et al., 2001).  
 
Fig. 1. Structure of different isomers of C16 (Willett, 2006) 
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Fat is a thus major source of energy for the body, and it also aids in the absorption of 
vitamins A, D, E and K, and of the carotenoids. Both animal-derived and plant-derived food 
products contain fat, and when eaten in moderation, fat is important for correct growth and 
development, and for the maintenance of good health. As a food ingredient, fat provides 
taste, consistency and stability, and helps us to feel ‘full’. In addition, parents should be 
aware that fats are an especially important source of calories and nutrients for infants and 
toddlers (up to 2 years of age), who have the highest energy needs per unit body weight of 
any age group.  
However, SFAs and TFAs raise low-density lipoprotein (LDL; or ‘bad’) cholesterol levels in 
the blood, thereby increasing the risk of heart disease. Indeed, prospective epidemiological 
studies and case-control studies support a major role for TFAs in the risk of cardiovascular 
disease, and therefore dietary cholesterol can also contribute to heart disease (see below). 
Unsaturated fats, which can be mono-unsaturated or polyunsaturated, do not raise LDL 
cholesterol and are beneficial to health when consumed in moderation. 
Hydrogenated oils tend to have a higher TFA content than oils that do not contain 
hydrogenated fats. In the partially hydrogenated soybean oil, which is the major source of 
TFAs worldwide, the main isomer is trans-10 C18:1. In the European countries with the 
highest TFA intake (The Netherlands and Norway), consumption of partially 
hydrogenated fish oils was common until the mid-1990s, after which they largely 
disappeared from the dietary fat intake. These partially hydrogenated fish oils included a 
variety of very-long-chain TFAs. Recent findings from Asian countries (India and Iran) 
have indicated a very high intake of TFAs from partially hydrogenated soybean oil (4% of 
energy). Thus, TFAs appear to be a particular problem in developing countries where 
soybean oil is used.  
Formation of these trans double bonds thus impacts on the physical properties of a fatty 
acid. Fatty acids that contain a trans double bond have the potential for closer packing and 
alignment of their acyl chains, which will result in decreased molecular mobility (Willett, 
2006). Therefore, the oil fluidity will be reduced when compared to that of fatty acids that 
contain a cis double bond. Partial hydrogenation of unsaturated oils results in the 
isomerisation of some of the remaining double bonds and the migration of others, 
producing an increase in the TFA content and a hardening of the fat. It has been shown that 
foods that contain hydrogenated oils tend to have a higher TFA content than those that do 
not contain hydrogenated oils (Moss, 2006; Oomen et al., 2001). Nevertheless, the 
hydrogenation of oils, such as corn oil, can result in both cis and trans double bonds, which 
are generally located anywhere between carbon 4 and carbon 16 of the fatty acids. One of 
the major TFAs is elaidic acid (trans-9 C18:1), although during hydrogenation of 
polyunsaturated fatty acids (PUFAs), small amounts of several other TFAs are produced, 
including: trans-9,cis-12 C18:2; cis-9,trans-12 C18:2; cis-9,cis-12,trans-15 C18:3; and cis-5,cis-
8,cis-11,cis-14,trans-17 C20:5 (Craig-Schmidt, 2006; Wagner et al., 2008). Conversely, one way 
to produce ‘zero’ levels of TFAs is through the trans-esterification reaction between 
vegetable oils and solid fatty acids, like C8:0, C12:0, C14:0 and C16:0. 
Correlations between high intake of industrially produced TFAs (IP-TFAs) and increased 
risk of coronary heart disease (CHD) have been reported (Stender et al., 2006; Tarrago-Trani 
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et al., 2006), and lowering the intake of TFAs can also reduce the incidence of CHD (Willett, 
2006). Estimates based on changes in plasma concentrations of LDL and high-density 
lipoprotein (HDL) indicate around a 4% reduction in CHD incidence, while based on 
epidemiological associations, when TFA intake is lowered by 2% (5 g/day), the estimates 
indicate a >20% reduction in CHD incidence (Katan, 2006; Moss, 2006). In The Netherlands, 
a major reduction in the TFA content of retail foods was achieved in the 1990s through the 
efforts of the industry and with minimal government intervention. Society pressure is also 
now helping to reduce the TFA content of ‘fast foods’. This illustrates the feasibility of 
reducing TFAs in fast foods without increasing the saturated fats, with the daily intake kept 
as low as possible, to minimise the health risks (Stender et al., 2006). 
Comparison of the different recommendations for macronutrients in some European 
countries, for the World Health Organisation/ Food and Agriculture Organisation of the 
United Nations (WHO/FAO), and in the USA and Canada, are given in Table 1. Most of the 
recommendations are the same, or are in similar ranges. The recommendations for protein, 
however, are expressed differently, either as grams per day or grams per kilogram per day, 
and usually without any indication of a representative weight at each age to allow 
conversion of one to the other. The Joint FAO/WHO/United Nations University (UNU) 
Expert Consultation of 1985 (WHO, 1985) defined the protein requirement of an individual 
as “the lowest level of dietary protein intake that will balance the losses of nitrogen from the 
body in persons maintaining an energy balance at modest levels of physical activity”. The 
human body can synthesise both SFAs and mono-unsaturated fatty acids (MUFAs) from 
acetate, whereas PUFAs (in both the n–6 linoleic acid and n–3 linolenic acid series) are 
required in the diet, and they are therefore known as essential fatty acids. These essential 
fatty acids are important for various cell-membrane functions, such as fluidity, permeability, 
activity of membrane-bound enzymes and receptors, and signal transduction. Linoleic and 
linolenic acids can be elongated and desaturated in the body, and transformed into 
biologically active substances, like prostaglandins, prostacyclins and leukotrienes. These 
substances participate in the regulation of blood pressure, renal function, blood coagulation, 
inflammatory and immunological reactions, and many other functions (Nordic Nutrition 
Recommendations, 2004). The DACH Reference Values for Nutrient Supply (DACH, 2000) 
for total fat intake in adults (not more than 30% of the energy intake) are related to light 
work, heavy muscle work (not more than 35% of energy intake) and extremely heavy work 
(not more than 40% of energy intake). SFAs should not exceed 10% of energy intake. PUFAs 
should provide about 7%, and up to 10% if SFAs provide more than 10% of energy intake. 
MUFAs should constitute the rest. TFAs should contribute not more than 1% of the daily 
energy. The ratio of n–6 linoleic acid to n–3 linolenic acid should be about 5:1 (WHO/FAO, 
2002). These fatty acids compete for the metabolic enzymes, and it is therefore important to 
maintain a balance between them (Nordic Nutrition Recommendations, 2004). The Nordic 
Nutrition Recommendations indicate the limiting of the intake of SFAs plus TFAs to about 
10% of the daily energy and the total fat intake to 30% of the daily energy (25%-30%) (Filip 
et al., 2010). The recommendations for carbohydrate intake are from 50%of the daily energy 
in the DACH (2000) reference values, to 55% (50%-60%) in the Nordic Nutrition 
Recommendations (2004), 55%-75% by WHO/FAO, and 45%-65% in the USA/ Canada 
recommendations, as detailed in Table 1. 
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Component 
NNR 
(2004) 
DACH 
(2000) 
WHO/FAO 
(2002) 
Euro Diet 
(2000) 
USA/Canada 
AMDR 
(2002) 
Total energy from fat 
(%) 
30 (25-35) 30 15-30 <30 20-35 
SFAs (%) ≤10 10 <10 <10 Minimise 
PUFAs (%) 5 (10) 7-10 6-10 - - 
n-6 FAs (%) 4 (9) 2.5 5-8 4-8 5-10 (linoleic) 
n-3 FAs (%) 1 0.5 1-2 2 (linolenic) 0.6-1.2 
TFAs (%) 
Included 
in SFAs 
1 <1 <2 Minimise 
MUFAs (%) 10-15 The rest of the total - 
Total energy from 
carbohydrates (%) 
55 (50-60) 50 55-75 >55 45-65 
Energy from sugars 
(%) 
<10 30 <10 <25 
Fibre (g/day) 25-35 (3 g/MJ) (12.5 g/1000 kcal) 
25-38 
(14 g/1000 
kcal) 
Energy from proteins 
(%) 
15 (10-20) 8-10 10-15 - 10-35 
Cholesterol (mg/day) 300 <300 Minimise 
Salt (sodium) (g/day) 5–6 (2.3-2.7) <5 (2) 
NNR, Nordic Nutrition Recommendations; DACH, Austria–Germany–Switzerland Reference Values 
for Nutrient Supply; WHO, World Health Organisation; FAO, Food and Agriculture Organisation of the 
United Nations; AMDR; acceptable macronutrient distribution; FAs, fatty acids; SFAs, saturated fatty 
acids; PUFAs, polyunsaturated fatty acids; TFA, trans fatty acids; MUFAs, mono-unsaturated fatty 
acids.  
Table 1. Comparison of reference daily intakes for adults according to different 
recommendations around the World (Pavlovic et al., 2007) 
As indicated above, prospective epidemiological studies and case-control studies using 
adipose-tissue analyses have confirmed a major role for TFAs in the risk of CHD. The 
magnitude of the association with CHD is considerably stronger than for SFAs, and it is 
stronger than that predicted for the effects of TFAs on LDL and HDL cholesterol (Katan, 
2006; Tarrago-Trani et al., 2006). In this context, it needs to be considered that data for the 
Russian Federation show that every year 1,005 people per 100,000 of the population between 
25 and 64 years of age die because of circulatory system diseases (WHO, 2008). As a 
consequence influence of TFAs on CHD, in 2003, the United States FDA issued a ruling that 
required food manufacturers to list the TFAs in the nutritional facts labels of all packaged 
food products (FDA, 2003), with the food industry being given until 1 January, 2006 to 
comply. Along with these growing health concerns about TFAs, this mandate led to marked 
changes in the fat and oil industries, with newer technologies developed to reduce the TFA 
contents of fats and oils used in the manufacture of food products. Conversely, given the 
labelling mandate and these technological advances, it is possible that food products 
traditionally considered to be sources of TFAs are now much lower in, or indeed do not 
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contain, TFAs (Borra et al., 2007). Then in late 2006, New York City became the first major 
city in the United States to pass a regulation limiting IP-TFAs in restaurants. This has served 
as a model for others to follow, with these regulations including: a maximum level per 
serving size of 0.5 g TFAs; a distinction between frying and baking, with a phased-in 
implementation; a help centre to assist restaurants to make the switch to more healthy 
options; and plans to evaluate the regulation and its impact on CHD (Borra et al., 2007). 
Accurate quantification of C18:1 TFAs in food products is thus an important issue, with 
policies recently implemented in different countries to limit their consumption and their 
occurrence in food products because of their relationship with CHD (Carriquiry et al., 2008; 
Chen et al., 2007). 
2. History  
Margarine was invented in 1869 by Hippolyte Mège Mouriès, a French food research 
chemist, in response to a request by Napoleon III for a wholesome alternative to butter. It is 
not entirely clear whether the primary aim was the betterment of the working classes or the 
economics of the food supply to the French army. In the laboratory, Mège Mouriès solidified 
purified fat, after which the resulting substance was pressed in a thin cloth, which formed 
stearine and discharged oil. This oil formed the basis of the butter substitute. For the new 
product, Mège Mouriès used margaric acid, a fatty-acid component isolated in 1813 by the 
Frenchman Michel Eugène Chevreuil. While analysing the fatty acids that are the building 
blocks of fats, he singled out this one and named it margaric acid, because of the lustrous 
pearly drops that reminded him of the Greek word for pearls, i.e. margarites (Chen et al., 
2008; Craig-Schmidt, 2006). 
In 1871, Mège Mouriès sold this know-how to the Dutch firm Jurgens, which is now part of 
Unilever. In the early days, margarine contained two types of fat: a large proportion of 
animal fat and a small proportion of vegetable fat. As time passed, the small vegetable-fat 
element increased, through two specific stages in the process. First, by improving the 
process of refining vegetable oils, use could be made of a greater variety of liquid oils and a 
higher proportion of solid vegetable fats. Secondly, through the development of processes 
for turning liquid oils into solid fats on a commercial scale, use could be made of larger 
quantities of liquid vegetable oils (Filip, 2010). 
During the early years of this period, in the late 1800s, TFA intake from partially hydrogenated 
vegetable oils was minimal. Indeed, it was not until the late 1800s that the process of partial 
hydrogenation of oils was invented in Europe. These partially hydrogenated oils apparently 
entered the United States food supply by 1920. Although the rate of increase before 1950 is not 
completely clear, by 1950 the amount of IP-TFAs in the food supply was quite substantial. 
Partly because of economic effects during World War II, margarine production rose rapidly as 
a replacement for butter (Chen et al., 2007). Then during the 1960s, margarine became viewed 
as a healthy alternative to butter because of its absence of cholesterol and its low content of 
SFAs. Thus, consumption increased further, and so margarine, which was heavily 
hydrogenated at that time, became widespread in the food supply and was the major source of 
IP-TFAs. This phenomenon is illustrated in Figure 2. The total TFAs consumption was 
approximately 2% to 3% of the food energy. Since then, the sources of TFAs have changed, 
from mainly margarine to mainly deep-fried fast foods and commercially baked products, 
although per capita, the intake has remained roughly the same (Willett, 2006). 
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Fig. 2. Relative food energy supplied by the different fatty acids, and the predicted changes 
for the food industry and fat hydrogenation (Simopoulos, 2004) 
After World War II, the process of making hydrogenated and hardened fats from cheaper 
sources of vegetable oils was widely adopted. Margarines were developed and marketed as 
alternatives to butter, and vegetable shortening increasingly replaced animal fats in cooking 
(Albers et al., 2008). However, as early as 1975, at what is now the University of Glamorgan 
in South Wales, a group of scientists led by Leo Thomas suspected that deaths from CHD 
were connected with this eating of partially hydrogenated fats. It is now generally accepted 
that TFAs are actually worse for health than the SFAs that they were designed to replace 
(Blake, 2009). 
3. Studies of trans fatty acids 
Increases in ‘civilization diseases’ in the developed world led scientists to investigate why 
this was happening. While there is enough food that is also cheaper and more accessible 
than ever before in the developed world, we are witnessing more and more overweight and 
obese populations. Modern populations have worse nutrition habits than ever before, except 
for some specific small social groups e.g. through religion, ecology and ethnic aspects 
(WHO, 2008). Obesity is a severe health issue that is characterised by fat accumulation and 
defined by means of the body mass index (BMI), as body weight [kg]/ (height [m])2. 
According to this index, different obesity levels have been described, ranging from 
overweight (BMI, 25.0-29.9), through obese (BMI, 30.0-40.0) to the most detrimental stage, 
morbid obesity (BMI, ≥40) (Garaulet et al., 2011). The relevance of this classification is that as 
the BMI increases, the morbidity and mortality risks also increase (Bray, 2003). Furthermore, 
regional fat accumulation is an important factor in the development of obesity-related 
alterations. It has been suggested that excess visceral fat is more detrimental than excess 
www.intechopen.com
 
Trans Fatty Acids and Human Health 
 
49 
subcutaneous fat, because visceral deposits release free fatty acids directly into the portal 
vein (Bray, 2003). The fatty acid pattern carried to the portal circulation is of great 
importance, because different fatty acids show distinct atherogenicities, depending on the 
chain length and degree of unsaturation. Here, SFAs have been associated with increased 
cardio-metabolic risk, while n-3 and n-9 unsaturated fatty acids have been proposed as 
protective agents against these alterations (Garaulet et al., 2011). 
3.1 Studies in animals 
In milk fat, TFAs are produced by anaerobic fermentation of PUFAs in the rumen of 
lactating cows (Destaillats et al., 2007; Fournier et al., 2006). This fermentation process is 
called biohydrogenation, and it results in TFAs that can be further metabolised in the 
mammary gland. Accurate estimations of fatty-acid compositions are vital not only for the 
definition of the nutrient composition of foods, but also to accurately determine treatment 
effects that can alter the fatty-acid composition of the foods (Ascherio, 2002; Burdge et al., 
2005; Kummerow et al., 2004; Murrieta et al., 2003; Triantafillou et al., 2003).  
There is a considerable overlap of TFA isomers in fats of ruminant origin and in partially 
hydrogenated vegetable oils, as they have many isomers in common. However, there are 
considerable differences in the amounts of individual TFAs in these sources. While there is 
evidence of unfavourable effects of TFAs from hydrogenated vegetable oils on LDL and 
other risk factors for atherosclerosis, at present it is not certain which of the component(s) of 
the TFAs created by chemical hydrogenation are responsible for these a negative metabolic 
effects (Ascherio, 2002). Prospective studies addressing the effects of TFA intake on CHD 
risk, where estimates of TFA intake were based on dietary protocols, have mostly been 
carried out in populations with a relatively low intake of dairy or ruminant TFAs (Pfeuffer 
& Schrezenmeir, 2006). Nevertheless, the biggest effects of fatty-acid composition and the 
nutritive quality of foods of animal origin, like meat and milk products, depend on the feed 
quality and the health of the animals. 
3.2 Studies in humans 
These TFA-containing fats can be incorporated into both foetal and adult tissues, although 
the transfer rate through the placenta continues to be a contradictory subject. In preterm 
infants and healthy term babies, the trans isomers have been inversely correlated with infant 
birth mass (Koletzko & Müller, 1990). Maternal milk reflects precisely the mother’s daily 
dietary intake of TFAs, with presence of 2% to 5% total TFAs in human milk. The levels of 
linoleic acid in human milk are increased by a high trans diet, although long-chain 
polyunsaturated TFAs remain mostly unaffected (Koletzko, 1992; Koletzko & Desci, 1994). 
Alterations in the maternal dietary intake of PUFAs cause similar changes in the PUFA 
content of their milk. Several investigations have shown that supplementation of the 
consumed fat with fish oils increases the amounts of C20:5n-3 and C22:6n-3 in the milk and 
in the maternal and infant erythrocyte lipids. Likewise, infant tissues incorporate the TFAs 
from the maternal milk, increasing the levels of linoleic acid and decreasing arachidonic acid 
and docosahexaenoic acid. This suggests an inhibitory effect of TFAs on the liver n-6 fatty-
acid-desaturase activity (Jensen et al., 1992).  
www.intechopen.com
 
The Cardiovascular System – Physiology, Diagnostics and Clinical Implications 
 
50
As opposed to blood and liver, the brain appears to be protected from TFA accumulation in 
experimental animals, although no data have yet been reported for newborn humans 
(Larqué, 2001). A significant interaction between diet and pregnancy was shown for the 
activities of Δ6-desaturase and glucose 6-phosphatase in liver microsomes: dietary TFAs 
decreased the activities of both of these enzymes, although only in pregnant rats (Larqué et 
al., 2000; Larqué & Zamora, 2000; Larqué et al., 2003). In Spain, TFAs in human milk were 
investigated by Boatella et al. (Boatella et al., 1993), and they showed that the average 
content of TFAs in 38 samples was 0.98% of the milk fatty acids. This value is lower than 
that for human milk from other developed countries, where consumption of hydrogenated 
fats is higher. In a study by Chen et al. (Chen et al., 1995) on TFAs in human milk in Canada, 
the mean total TFA content was 7.19% (±3.03%) of the total milk fatty acids, with a range 
from 0.10% to 17.15%. 
The compelling data linking dietary TFAs to increased risk of CHD have originated from 
large, prospective, population-based studies, which included from 667 to 80,082 men and 
women across different age groups who were monitored for six to 20 years. This link has 
also been seen in controlled feeding trials (Oomen et al., 2001). Among these studies, there 
are: the United States Health Professional’s follow-up study; the Finnish alpha-tocopherol, 
β-carotene Cancer Prevention Study; the United States nurse’s health study (with 14-year 
and 20-year follow-up) (Willett, 2006); and the Dutch Zutphen elderly study (Oomen et al., 
2001). These studies are consistent in their finding of a strong positive association between 
TFA intake and the risk of CHD. Interestingly, a weaker correlation between SFA intake and 
the risk of CHD also has been reported (Willettt, 2006). 
The Zutphen elderly study included 667 men from 64 to 84 years of age who were free of 
CHD at baseline (Oomen et al., 2001). Dietary surveys were used to establish the food 
consumption patterns of the participants. Information on risk factors and diet were obtained 
in 1985, 1990 and 1995. After a 10-year follow-up, from 1985-1995, there were 98 cases of 
fatal or non-fatal CHD. The findings showed that over this period, the mean TFA intake 
decreased from 4.3% to 1.9% of the food energy. After adjustments for age, BMI, smoking 
and dietary covariates, TFA intake at baseline was positively associated with 10-year risk of 
CHD. Thus, a high intake of TFAs, which included all types of isomers, contributed to the 
risk of CHD. A substantial decrease in TFA intake, which was mainly due to the lowering of 
the TFA content in edible fats in the Dutch industry, therefore had a large impact on public 
health (Craig-Schmidt, 2006; Larqué et al., 2001). 
In multiple and rigorous randomised trials, the intake of TFAs has been consistently shown 
to have adverse effects on blood lipids, and most notably on the LDL/HDL cholesterol ratio, 
which is a strong marker of cardiovascular risk. When a mixture of TFA isomers obtained by 
partial hydrogenation of vegetable oils is used to replace oleic acid, there is a dose-
dependent increase in the LDL/HDL ratio. The relationship between the levels of TFAs as 
the percentage of energy and the increase in the LDL/HDL ratio appears to be 
approximately linear, with no evidence of a threshold at low levels of TFA intake, and with 
a slope that is twice as steep as that observed by replacing oleic acid with a SFA (Borra et al., 
2007; Mensink & Nestel, 2009). Studies comparing animal and vegetable TFAs have shown 
similar effects on the total/HDL cholesterol ratio. The effects of TFAs on lipoproteins from 
both sources appeared at doses exceeding 2% of energy (Mensink & Nestel, 2009). The 
average impact of TFA-induced changes in the LDL/HDL ratio corresponds to tens of 
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thousands of premature deaths in the United States alone (Mensink & Nestel, 2009). 
Although dramatic, this effect is substantially smaller than the increase in cardiovascular 
mortality associated with TFA intake in epidemiological studies, suggesting that other 
mechanisms are likely to contribute to the toxicity of TFAs (Ascherio, 2006). Thus, although 
there is accumulating evidence linking inflammatory proteins and other biomarkers to 
CHD, lipid concentrations in the blood remain one of the strongest and most consistent 
predictors of risk. Therefore, the LDL/HDL cholesterol ratio is probably the best marker to 
date for estimating the effects of TFAs on plasma lipids, which are most likely relevant to 
CHD incidence and mortality (Larqué & Zamora, 2001). 
Further rigorous randomised trials to establish the effects of hydrogenated fats and TFA 
intake on individual lipoprotein classes started in 1990, when a report from The Netherlands 
suggested that a diet enriched in elaidic acid (trans-9 C18:1) increases the total and LDL 
cholesterol concentrations and decreased HDL cholesterol concentrations, compared to a 
diet enriched in oleic acid. In contrast, enrichment of the diet with SFAs increases LDL 
cholesterol, but has no effect on HDL cholesterol, thus resulting in a smaller adverse change 
than in the case of elaidic acid (Mensink & Katan, 1993; Mensink & Nestel, 2009). 
3.3 Studies of antioxidant effects 
In one study (Filip et al., 2011), the effects of natural antioxidants on formation of TFAs 
during heat treatment of sunflower oil was investigated. The data from the fatty acid 
analyses are summarized in Table 2. Here, the non-treated control sunflower oil had a 7.5% 
palmitic acid content, with 4.5% stearic acid, 25.0% oleic acid, and 60.5% linoleic acid, as is 
usual for the common (not high in oleic acid) sunflower oils; these data compare well with 
those of other studies (Sánchez-Gimeno et al., 2008; Bansal, Zhou, Tan, Neo, & Lo, 2009). 
This sunflower oil was purchased directly from a supplier of oils that are used mainly by 
small food enterprises (Zvijezda d.d., Zagreb, Croatia). The natural antioxidant extract of 
rosemary (Rosmarinus officinalis L.) that was added to this sunflower oil (SOR) was 
purchased directly from Vitiva d.d., Markovci, Slovenia (INOLENS4®; Product N° 301770; 
Batch N°. LAB. 09-779004), and had a carnosic acid content of 4.30%. Similarly, the lutein 
added to this sunflower oil (SOL) was from pelargonium (2.2% mixture), as obtained from 
Etol, d.o.o., Celje, Slovenia (NovaSoL® Lutein; Aquanova AG, Birkenweg 8-10, Germany). 
The initial levels of the total TFAs in the samples was 0.91% (±0.01%). This compares with 
the range from 0.15% to 6.03% reported by Bansal et al. (2009) for TFAs in refined oils 
(soybean, corn, sunflower, high oleic sunflower, low erucic rapeseed and high erucic 
rapeseed oils). The aim in this study with the sunflower oil was to evaluate the effects of 
heat on this TFA composition of the oil when subjected to treatment representative of deep-
fat frying (185 ±5°C). Since sunflower oil is in common use for deep-fat frying, it is 
particularly important to know what species and levels of TFA isomers appear during such 
heat treatment (Filip et al., 2011; Martin et al., 2007). 
In this study, we focussed mainly on these effects of heat on the TFAs with 18 carbon atoms, 
which were the most represented. Prior to the treatment, the content of trans C 18:1, t-9 was 
0.67% (±0.08%). At the end of the heat treatment (120 h at 185 ±5°C), in the control sunflower 
oil the trans C 18:1, t-9 increased to 1.12% (±0.14%), in SOR, to 0.99% (±0.04%), and in SOL, to 
0.91% (±0.01%). Within each treatment, these increases were significantly different from the  
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Component Time (h) 
 0 24 48 72 96 120 
Sunflower oil (control) 
SFAs (%) 12.43 ±0.13b 12.54 ±0.12b 12.77 ±0.58b 14.02 ±0.49ab 14.62 ±2.63b 14.76 ±0.35a 
MUFAs (%) 26.13 ±0.68d 28.56 ±1.22c 29.40 ±1.06cb
29.84 
±0.85abc 
31.18 ±0.96ab 31.59 ±0.35a 
PUFAs (%) 61.44 ±0.75a 58.50 ±1.23b 57.83 ±1.33b 56.14 ±1.15bc 56.20 ±3.01bc 53.64 ±2.08c 
n6 PUFAs 
(%) 
61.13 ±0.76a 58.20 ±1.23b 57.82 ±1.34b 55.64 ±1.17bc 55.66 ±3.03bc 53.05 ±2.08c 
n3 PUFAs 
(%) 
0.31 ±0.02b 0.30 ±0.00b 0.31 ±0.02b 0.34 ±0.01a 0.35 ±0.02a 0.36 ±0.01a 
n6/n3 
199.93 
±15.84a 
192.92 
±4.71a 
185.41 
±11.56a 
163.68 
±7.73b 
159.78 
±16.01b 
149.37 
±6.99b 
TFAs (%) 0.91 ±0.03d 0.99 ±0.06d 1.25 ±0.07c 1.46 ±0.15b 1.56 ±0.09b 1.71 ±0.07a 
Sunflower oil with rosemary extract (SOR; 1.0g/kg oil) 
SFAs (%) 12.39 ±0.57c 12.70 ±0.48c 12.74 ±0.41c 13.80 ±0.29b 14.02 ±0.70ab 14.68 ±0.61a 
MUFAs (%) 
25.72 
±1.92bc 
25.37 ±1.67c
28.73 
±0.81ab 
25.69 ±3.46bc 28.87 ±0.40ab 30.25 ±2.24a 
PUFAs (%) 61.88 ±1.67a 61.93 ±1.43a
58.53 
±0.57bc 
60.51 ±3.33ab 57.11 ±0.55cd 55.07 ±1.71d 
n6 PUFAs 
(%) 
61.58 ±1.66a 61.62 ±1.43a
58.13 
±0.56bc 
60.07 ±3.32ab 56.56 ±0.57cd 54.45 ±1.72d 
n3 PUFAs 
(%) 
0.31 ±0.02b 0.31 ±0.01b 0.31 ±0.01b 0.33 ±0.01a 0.33 ±0.01a 0.35 ±0.01a 
n6/n3 
201.53 
±10.73a 
198.56 
±6.72a 
186.36 
±5.67b 
179.91 
±9.26bc 
169.54 
±7.89c 
154.65 
±3.96d 
TFAs (%) 0.91 ±0.09d 0.82 ±0.02d 1.02 ±0.05c 1.24 ±0.20c 1.35 ±0.10b 1.55 ±0.16a 
Sunflower oil with lutein (SOL; 0.1g/kg oil) 
SFAs (%) 12.51 ±0.72c 12.36 ±0.35c 13.06 ±0.36bc 13.21 ±0.65bc 13.91 ±0.54ab 14.84 ±0.96a 
MUFAs (%) 26.25 ±2.60b 25.05 ±0.64b 28.22 ±2.49b 27.55 ±2.79b 28.07 ±0.85b 32.79 ±1.63a 
PUFAs (%) 61.24 ±2.82ab 62.59 ±0.72a 58.72 ±2.47b 59.24 ±3.15b 58.02 ±1.37b 52.37 ±0.74c 
n6 PUFAs 
(%) 
60.93 ±2.83ab 62.29 ±0.72a 58.31 ±2.48bc 58.80 ±3.15bc 57.51 ±1.40c 51.80 ±0.73d 
n3 PUFAs 
(%) 
0.31 ±0.02b 0.31 ±0.01b 0.32 ±0.01ab 0.33 ±0.02ab 0.33 ±0.02ab 0.35 ±0.03a 
n6/n3 
199.10 
±16.69ab 
203.99 
±5.54a 
180.24 
±9.67bc 
177.99 
±19.87c 
174.65 
±12.92c 
149.07 
±10.26d 
TFAs (%) 0.91 ±0.06c 0.84 ±0.03c 1.01 ±0.02b 1.23 ±0.16b 1.28 ±0.11b 1.43 ±0.04a 
SFAs, saturated fatty acids; MUFAs, mono-unsaturated fatty acids; PUFAs, polyunsaturated fatty acids; 
TFAs, trans fatty acids; a, b, c, d Values followed by a different letter are significantly different along each 
row according to the Duncan test (P <0.05);  
Table 2. Effect of cooking heat (185 ±5°C) on the fatty acids composition of sunflower oil, 
with the addition of the natural antioxidants of a rosemary extract (SOR) and of lutein (SOL) 
(Filip et al., 2011) 
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start to the end of the treatment (P <0.001), and also the decreases in trans C 18:1, t-9 
production with the addition of rosemary oil and lutein were statistically significant in 
comparison with the control (SOR vs. sunflower oil: 0.32% vs. 0.45%; SOL vs. sunflower oil: 
0.24% vs. 0.45%; P <0.001 for both). These data are consistent with an earlier report where 
there were reductions in trans-isomerisation and polar compounds in model oils when α-
tocopherol (1%) was added as an antioxidant (Tsuzuki et al., 2008). 
When the content of the total TFAs is expressed as the sum of the unsaturated FAs with at 
least one trans double bond, these increased significantly from the initial control sunflower 
oil of 0.91% (±0.03%), to 1.71% (±0.07%) at 120 h, with significantly lower increases for SOR 
and SOL, to 1.55% (±0.16%) and 1.43% (±0.04%), respectively (Table 2). Indeed, these 
differences among treatments were statistically significant (P <0.001) at each step of the heat 
treatment (24, 48, 72, 96, 120 h). These data relating particularly to the increases in TFAs are 
comparable to those of Gamel et al. (1999), where they looked at the effects of phenol 
extracts on TFA formation during frying. A linear relationship between the amounts of 
elaidic acid and the number of frying cycles has also been reported (Bansal et al., 2009).  
According to the nutritional recommendations of the various health authorities, the content 
of SFAs should not exceed 30% in dietary fats. Sunflower oil thus fits into this 
recommendation, even though its content in the control sunflower oil increased from 12.43% 
(±0.13%) to 14.76% (±0.35%), and in the SOR and SOL to 14.68% (±0.61%) and 14.84% 
(±0.96%), respectively (Table 2). 
The initial PUFA:SFA ratio here was 4.94 (±0.10), and after the full time of the heat exposure 
for the control sunflower oil, this was significantly decreased to 3.64 (±0.14) (P ≤0.05). 
Meanwhile, , for the SOR and SOL at 120 h of heat treatment, the PUFA:SFA ratio decreased 
to 3.75 (±0.09; P <0.001) and 3.54 (±0.18; P <0.001). As higher PUFA/SFA ratios are more 
nutritionally appropriate, these data confirm that the heat treatments of this sunflower oil 
also worsened this nutritional factor. 
4. Trans fatty acids and legislation 
Governments are increasingly recognising that the risks to consumers from the increased 
consumption of TFAs cannot be ignored. In 2003, Denmark became the first country to 
introduce laws to control the sale of foods containing TFAs. This started with the 
publication of a study in The Lancet by Willett in 1993. Then the Danish Nutrition Council, 
which was established in 1992, was the driving force behind the campaign that convinced 
Danish politicians that IP-TFAs can be removed from foods without any effects on their 
taste, price or availability. The Nutrition Council argued that as no positive health effects of 
IP-TFAs had ever been reported, then just the suspicion that a high intake has harmful 
effects on health justified the ban (Astrup, 2006; Mjøs, 2003). The Danish success story might 
be interesting for other countries, where this unnecessary health hazard could also be 
eliminated from the foods. 
Then in January 2006, it became law in the United States that the contents of TFAs have to be 
specifically listed on food labels. There is a complication to this, however, because there 
were two reasons why the consumers might not see a TFA content on the label of a food 
product. First, although products entering interstate commerce on or after 1 January, 2006, 
had to be labelled, the FDA realized that it would take some time for food products to move 
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through the distribution chain to a store shelf. Then, foods that contain less than 0.5 g TFAs 
per serving can be labelled as being free from TFAs. Furthermore, in Europe, the declaring 
of TFAs on food labels is still not obligatory in many countries. At the same time, these 
regulations only applied to food that was labelled; food sold in restaurants and canteens 
was not covered by this law (FDA, 2003; Moss, 2006; Stender et al., 2006). Thus many still 
feel that foods that contain more than 4 g/100 g SFAs and TFAs together should not be 
claimed to be healthy food. Indeed, Danish law prohibits the sale of foods that contain more 
than 2 g TFAs per 100 g of fat, excluding food that naturally contains more TFAs (Filip et al., 
2010). Denmark decided to impose this maximum level of IP-TFAs as labelling was deemed 
insufficient to protect consumers, and especially for risk groups like children and adults 
with a high intake of fast foods (Garchés & Mancha, 1993; Leth et al., 2006). 
Then, in December 2006, the Board of Health of New York City banned many TFAs from 
restaurants in the city, prompting similar moves in Philadelphia, Montgomery County in 
Maryland, and the Boston suburb of Brooklyn. The first phase of the regulation applies to 
oils, shortening and margarine, used in cooking and as spreads, and for recipes that contain 
more than 0.5 g TFA per serving. Since 1 July, 2007, New York City officials have also called 
for restaurants to clearly display calorie counts next to their menu items, in a bid to increase 
consumer awareness of the nutritional content of their food. By 1 July, 2008, the ban had 
been extended to include TFAs used in baked goods, including bread and cakes, in prepared 
foods, salad dressings and oils used for deep frying, and in dough and cake batter. Similar 
bans are being proposed in Chicago and in the state of Illinois; other cities may follow suit, 
most likely in California (Albers et al., 2008; Blake, 2009). 
The American Heart Association recommends a healthy dietary pattern and lifestyle to 
combat heart disease, limiting TFA consumption to less than 1% (or approximately 2 g on a 
2,000-calorie diet), and saturated fat consumption to less than 7% of the total daily calories 
(Borra et al., 2007). This is consistent with the TFA recommendations made by the American 
Dietetic Association and the Dietitians of Canada (ADA, 2007). 
The benefits of adding TFAs on food Nutrition Facts labels in the United States means that 
consumers now know the levels of SFAs, TFAs and cholesterol in the foods that they choose 
to eat. This enables them to make heart-healthy food choices, to help them to reduce their 
risk of CHD. This labelling is also of particular interest to those concerned about high blood 
cholesterol. However, to gain the full benefit of this system, all of the consumers need be 
aware of the risk posed by consuming too high levels of SFAs, TFAs and cholesterol.  
At the same time, about half of the convenience products on the Austrian market that have 
been tested contained less than 1% TFAs, and one third less than 5% (Wagner et al., 2008). 
However, almost 5% of the products tested contained more than 20% TFAs. A similar level 
was seen for fast food products, with the highest TFA levels of 8.9%, while the total TFAs of 
household fats were significantly lower (1.45% ±1.99%) than fats for industrial use (7.83% 
±10.0%; P <0.001). Compared to investigations in Austria (and Germany) around 10 years 
ago, the TFA contents of foods have decreased significantly. About half of the investigated 
products contained less than 1% of TFAs or total fatty acids, although very high levels of 
TFAs (>15%) are still detected, and an intake of more than 5 g TFA per portion is possible, 
which has been shown to significantly increase the risk of CHD (Oomen et al., 2001; Wagner 
et al., 2008; Wilett, 2006). 
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5. Analytical methods for trans fatty acid determination 
The fatty acid composition of food is usually determined using gas-liquid chromatography 
of the corresponding fatty acid methyl esters (FAMEs) (Baggio et al., 2005; Bondia-Pons et 
al., 2004; Chen et al., 1999; Ratnayake, 1995; Ulberth & Henninger; 1992). Usually, the 
FAMEs can be conveniently prepared by heating lipids with a large excess of either acid-
catalysed or base-catalysed reagents. However, most of the analytical methods are time 
consuming and impractical for the processing of large numbers of samples, because the 
lipids have to be extracted prior to preparation of the FAMEs. For this reason, some 
procedures have been developed that can be used to prepare FAMEs directly from fresh 
tissue (Park & Goins, 1994; Garchés & Mancha, 1993). 
6. Consumption of trans fatty acids 
Vaccenic acid (trans-11 C18:1) accounts for over 60% of the natural TFAs, whereas with IP-
TFAs, a broad mixture of TFAs is produced, with elaidic acid (trans-9 C18:1) as the main 
product (Oomen et al., 2001). In recent years, new technologies have been developed to 
reduce the TFA content in fats and oils used in the manufacture of food products. As 
indicated above, the content of TFAs in Danish food has been monitored for the last 30 
years. In margarine and shortening, the TFA content has steadily declined, from about 10 g 
per 100 g of margarine in the 1970s, to practically no TFAs in margarine in 1999, to 
efficiently reduce the health risk related to TFAs.  
In North America, the daily TFA intake has been estimated using food frequency 
questionnaires, and it was found to be 3-4 g per person (ADA, 2007), while by extrapolation 
of human milk data, it was said to be greater than 10 g per person (Chardigny et al., 1995). 
The data also show that the levels of TFAs can vary considerably among foods within any 
specific category, reflecting the differences in the fats and oils used in the manufacturing or 
preparation processes. For example, the range of TFAs in 17 brands of crackers was from 
23% to 51% of the total fatty acids, which represents differences of 1 g to 13 g TFAs per 100 g 
of crackers. These data thus show that the wide variability in the TFA content of different 
foods can result in large errors in the estimation of the TFA intake of individuals, and 
potentially, of groups (Innis, 2006). 
TFA consumption in European countries varies considerably. The diet in northern European 
countries traditionally contains more TFAs than that in the Mediterranean countries, where 
olive oil is commonly used. The diet in France has always been relatively low in TFAs, because 
France has traditionally used predominantly ruminant fats, as compared to hydrogenated 
vegetable oils. A more recent decrease in dietary TFAs has been seen due to the modification 
of commercial fats and changes in consumer choice (Larqué et al., 2001). In the TRANSFAIR 
study (Poppel et al., 1998), which was based on a market basket analysis of diets across 14 
European countries, the mean daily intake of TFAs in European countries ranged from the 
lowest in Greece (1.4 g TFA per day) to the highest in Iceland (5.4 g TFA per day) (Fig. 3). 
The lover daily intake of TFAs was recorded in Greece where 1.4 g of TFAs are consumed 
per day what represent 0.6 % of daily energy intake. The highest daily intake of TFAs was 
recorded in Iceland where 5.4 g of TFAs are consumed per day what represent 2.0 % of daily 
energy intake. As shown by researches (Innis et al., 1999; Leth et al., 2006; Poppel et al., 
1998) the lowest TFA intake is more often in countries with Mediterranean type of nutrition 
habits (Mediterranean diet). 
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Fig. 3. Mean daily intake of TFAs across the European countries (Innis et al., 1999; Leth et al., 
2006; Poppel et al., 1998) 
6.1 Dairy products and trans fatty acids 
Milk fat is also the most abundant source of conjugated linoleic acids (CLAs), which are a 
group of geometrical and positional isomers of linoleic acid (LA cis-9,cis-12 C18:2). The 
major isomer of the CLAs in milk fat is cis-9, trans-11, and it represents 80 g to 90 g per 100 g 
of the total CLAs (Chardigny et al., 1995; Ledoux et al., 2005; Seçkim et al., 2005). Some of 
these fatty acids have biological, physiological and nutritional properties that are very 
interesting for consumer health, as especially seen for butyric acid and CLAs (Pandya & 
Ghodke, 2007). The CLAs are synthesised in ruminants both from dietary linoleic acid (cis-
9,cis-12 C18:2) in the rumen by the microbial flora, and from vaccenic acid (trans-11 C18:1) in 
the mammary glands during de-novo synthesis (Bauman & Griinari, 2001).  
6.2 Industrially produced fat and trans fatty acids 
Brát and Pokorný (Brát & Pokorný, 2000) investigated a series of 20 margarines, nine 
cooking fats, and butter that were available on the Czech market. They used the American 
Oil Chemistry Society standard analysis methods, with capillary gas chromatography. The 
margarines contained 15.2% to 54.1% cooking fats, and 16.5% to 59.1% SFAs, which was less 
than the butter. The content of linoleic acid varied between 3.7% and 52.4% in the 
margarines; small amounts of linolenic acid were present in most samples, while oleic acid 
prevailed in the cooking fats. Monoenoic TFAs were present only in trace amounts in 10 
samples, and trans-polyenoic acids were present only in small amounts. Most cooking fats 
had a high content of TFAs. They summarised these data by indicating that the number of 
trans-free margarines had rapidly increased over a few years. 
More recently, Cenčič-Kodba (Cenčič-Kodba, 2007) examined 13 margarines and fatty food 
samples in Slovenia, which were selected according to the frequency of use among the 
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population group in the community. All of the fried food and bakery food samples included 
in this study contained TFAs, the levels of which varied from less than 0.5% to 6.8%. The 
highest TFA content in the margarines was 5.2%, with 0.3% as the lowest, and a mean 
margarine TFA content of 2.3%. The main TFAs were the trans isomers of mono-unsaturated 
octadecenoic acid (C18:1). 
Similarly, the findings of Larqué et al. (Larqué et al., 2003) suggest that Spanish margarines 
have moved to becoming products with a potentially healthier distribution of fatty acids. 
Even so, the great variability shown in the fatty-acid compositions of margarines and the 
poor labelling continue to highlight the importance of greater consumer information to 
avoid detrimental changes to the traditional Mediterranean diet in Spain. 
7. Conclusions and future trends 
It can be concluded at present that the reduction of TFAs in the food supply is a complex 
issue that has involved, and still involves, interdependent and interrelated stakeholders. 
Any further actions taken to reduce TFAs need to be carefully considered, regarding both 
the intended and unintended consequences related to nutrition and public health. As shown 
above, the WHO (WHO/FAO, 2002) has already included TFA levels in their recommended 
daily food intake (Table 1). Many different options of alternative oils and fats can now be 
used to replace TFAs, as many of these are already available, while others are still being 
developed. However, decisions on which alternatives to use are complicated and often time 
consuming, and they involve considerations of health effects, food availability, quality and 
taste, research and development investments, supply-chain management, operational 
modifications, consumer acceptance, and cost (Borra et al., 2007; FDA, 2003). 
As industry responses are now well underway following the policy actions over the past 
few years, it is possible to take a present-day ‘snapshot’ of industry activities that provide 
preliminary answers to these considerations. The first results of most of the anti-trans fat 
campaigns can be seen as modifications that have been made to the fatty-acid compositions 
of industrial fats. In these fats, there are significantly higher levels of SFAs and possibly a 
higher index of atherogenicity. Several major food companies have announced efforts to 
remove TFAs from their leading brands over the past two decades, starting with Unilever in 
the 1990s, and then more recently with Nestlé in 2002, Kraft in 2003, Campbell’s in 2004 (for 
Goldfish crackers), Kellogg’s in 2005, and Frito-Lay in 2006 (for chips). It is of note that the 
earliest announcements came from European firms, where the use of partially hydrogenated 
soy was not as common as it was in the United States, and thus this reformulation process 
has not been as onerous.  
The announcements over the last three years or so have reflected the attention brought to 
this issue through lawsuits and debates about nutritional labelling regulations. Many 
companies even chose to implement the disclosure of these trans-fat contents earlier than the 
January 1, 2006, deadline, particularly when they were able to advertise ‘zero’ trans fats on 
their products (Crisco, 2008). 
One aspect for producing such zero TFAs lies in the transesterification reactions between 
vegetable oils and the SFAs of C8:0, C12:0, C14:0 and C16:0. These reactions can be catalysed 
by an immobilised sn-1,3 specific Rhizomucor miehei lipase. When considering a TFA-free or 
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low TFA fat that is suitable for use as a confectionery fat, a non-hydrogenated vegetable fat 
composed of an inter-esterified fat can be used: this can be obtained by subjecting a blend of 
at least one fat rich in lauric acid and at least one fat without lauric acid to inter-
esterification (Farmani et al., 2007). 
For all of the products introduced in 2005 and 2006 that have claimed to contain no trans 
fats, the most commonly used oil ingredients have been canola, sunflower and soybean oils. 
Palm oil, which is high in saturated fat, also appears among the commonly used ingredients, 
but not as an alternative to reducing TFAs. Eleven percent of food producers in the United 
States still use partially hydrogenated oils as ingredient, because the regulations allow 0.5 g 
per serving of trans fats in products that claim to contain ‘no trans fat’, while the use of small 
amounts of partially hydrogenated oils has facilitated the reformulation of some products 
(Unnevehr & Jagmanaite, 2008). 
Between 2006 and 2007, consumer awareness of trans fats increased and attained levels 
similar to those for saturated fats. This increased awareness has been associated with 
improved self-reporting behaviour in consumer shopping for groceries (Eckel et al., 2009). 
However, food labels and food claims that accompany packed foods are still largely 
incomprehensible for consumers, and therefore they appear to be of very little use at 
present. Moreover, in Europe, consumers still cannot identify the content of TFAs in the 
labelling of food products, particularly as the only legislation that restricts the content of 
TFAs in Europe is in Denmark. 
At the same time, we have to be aware that indicators are showing that the world 
population is still increasing and is expected to reach nearly 8.9 thousand million 
(8,900,000,000) by the year 2050 (UN, 2004). Knowing of some of the problems that are 
associated with this increasing population, we are now combating the need that will arise 
for more and more potential food products to be used for biofuels (Fink & Medved, 2011). 
Thus, in the future, it will become increasingly difficult to assure food security and food 
safety, as well as the nutritional quality of food. Indeed, it is the nutritional quality of food 
and its distribution all over the World that are the main factors that will have a huge impact 
on human health. In this way, human health is more than just of personal value, as it is also 
part of the welfare of the whole of our society. 
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